RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Effective tax rate (%)

BrightPath Biotherapeutics Co., Ltd.【JP:4594】

Market cap
¥6.3B
P/E ratio
-5.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Mar 31, 2025-0.2+0.96%
Mar 31, 2024-0.2+27.17%
Mar 31, 2023-0.1-21.05%
Mar 31, 2022-0.2+17.32%
Mar 31, 2021-0.1-221.65%
Mar 31, 20200.1-150.69%
Mar 31, 2019-0.2-30.69%
Mar 31, 2018-0.3-28.29%
Mar 31, 2017-0.5+203.48%
Mar 31, 2016-0.1-84.54%
Mar 31, 2015-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)